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Philippe Demers, MD, FRCSC,a,b Montreal, Quebec, CanadaSutureless aortic valve replacement (AVR) has recently
emerged as a promising alternative to standard AVR in pa-
tients who have severe aortic stenosis and face a high sur-
gical risk.1 Because of the excellent survival associated
with mechanical mitral valve replacement, it is expected
that in the coming years an increasing number of elderly
patients who are seen for aortic stenosis will have previ-
ously undergone mitral valve replacement. The presence
of a mitral prosthesis is considered a contraindication to
sutureless AVR, however, because it has been speculated
to alter the geometry of the aortic root and left ventricular
outflow tract, thus interfering with deployment and stabil-
ity of the sutureless aortic bioprosthesis. Although trans-
catheter aortic valve implantation (TAVI) in the presence
of a mitral prosthesis has been reported in the literature,2
this to our knowledge is the first case report to describe su-
tureless AVR in a patient with previous mitral valve
replacement.
CLINICAL SUMMARY
A 75-year-old woman was admitted for progressive dys-
pnea of grade III to IV. The patient had a history of mitral
stenosis, for which she had undergone mitral replacement
21 years earlier with a mechanical prosthesis (Carbomedics
size 29 mm; Sorin Biomedica Cardio Srl, Saluggia, Italy).
The history was also positive for hypertension, hyperlipid-
emia, chronic atrial fibrillation, and an embolic stroke at age
39 years, with residual hemiparesis of the left inferior limb.A transesophageal echocardiogram revealed the presence
of severe aortic stenosis, with an aortic valve area of 0.3 cm2
and a mean gradient of 39 mm Hg. The mitral prosthesis
was totally functional, with no mitral regurgitation and a
mean gradient of 3 mm Hg. The length of the aortomitral
continuity was calculated at 10 mm (Figure 1). There was
also severe tricuspid regurgitation. The left ventricular ejec-
tion fraction was 60%.
The logistic euroSCORE II was calculated at 19.7%.
Surgical intervention was scheduled to correct the aortic
stenosis and tricuspid regurgitation. A median sternotomy
was performed, and cardiopulmonary bypass was initiated
with atriobicaval cannulation. The patient underwent
beating-heart tricuspid annuloplasty with a 30-mm
Carpentier-Edwards Physio ring (Edwards Lifesciences
Corp, Irvine, Calif), followed by sutureless AVR with a
23-mm Perceval S sutureless bioprosthesis (Sorin). Aortic
crossclamp and cardiopulmonary bypass times were 31
and 63 minutes, respectively. Weaning from bypass was
easy, and the patient was extubated on the same day.
The postoperative course was uneventful. The patient did
not demonstrate any conduction abnormalities; however,FIGURE 1. Preoperative transesophageal echocardiogram illustrating the
distance between the mitral prosthesis and the aortic annulus.
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FIGURE 2. Postoperative transesophageal echocardiogram showing
opening of the sutureless aortic bioprosthesis at midsystole.
Case Reportsshe was kept under surveillance for postoperative physical
deconditioning and discharged on postoperative day 15. A
predischarge echocardiogram showed an aortic valve area
of 1.9 cm2, a mean aortic transvalvular gradient of 11.6
mm Hg, no aortic paravalvular leak, and mild tricuspid
insufficiency. The mean gradient through the mitral pros-
thesis was 4 mm Hg, and there was no regurgitation. The
echocardiogram showed no evidence of interference be-
tween the aortic and mitral prostheses (Figure 2). The pa-
tient was seen 6 weeks after the operation and has
recovered well, with no residual symptoms.DISCUSSION
AVR is the standard treatment for severe symptomatic
aortic stenosis; however, the operative risk increases with
age, multiple comorbidities, and reoperation. In recent
years, sutureless AVR has emerged as a promising alterna-
tive for high-risk surgical patients. This approach allows
shorter aortic crossclamp times, which may be particularly
beneficial for elderly patients and those undergoing reoper-
ation or combined interventions.1
The presence of a mitral prosthesis is generally consid-
ered a contraindication to sutureless AVR because ofe28 The Journal of Thoracic and Cardiovascular Surgconcerns that the mitral device might alter the 3-dimen-
sional structure of the aortic root and left ventricular
outflow tract or directly interfere with the sutureless aortic
device. Nonetheless, deployment of an aortic self-
expanding device in the presence of a mitral prosthesis
has been shown to be feasible in the context of TAVI.2
Because the devices used in TAVI and sutureless AVR are
similar in design, it follows that these results should also
be reproduciblewith the latter technique. There must be suf-
ficient distance between the aortic andmitral annuli to avoid
the risk of interference between the two prostheses. In the
case of TAVI, a minimal distance of 10 mm has been
suggested.3
Sutureless AVR may reduce some of the complications
associated with TAVI, namely increased risks of postopera-
tive stroke, atrioventricular block, and paravalvular leak.4
Furthermore, a surgical approach allows the concomitant
correction of additional valvular or coronary disease, as
highlighted in this case report.
We report here the first case of sutureless AVR in the
presence of a mitral prosthesis. The procedure was carried
out successfully, with no early postoperative complications.
Follow-up studies are warranted to assess the long-term
durability of this technique. Extending the indication for su-
tureless AVR to elderly patients with previous mitral valve
replacement could improve the surgical outcomes in this
high-risk population.
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